Subtype
Large Intestinal Neoplasm
CI-CAN-00001062Explore in graph →
Non-malignant1,846 active trials21 approved drugs383 evidence items
- NCIt
- C215201
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001062Explore in graph →
Clinical trials
8,846 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00003786 | Irofulven in Treating Patients With Metastatic or Recurrent Colorectal Cancer | withdrawn | Phase 2 | 0 | University of ChicagoOTHER | 1 | Mar 7, 2014 | clinicaltrials |
| NCT00026468 | Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis | withdrawn | Phase 2 / Phase 3 | 0 | University of UtahOTHER | 0 | Jul 24, 2013 | clinicaltrials |
| NCT00003486 |
| Antineoplaston Therapy in Treating Patients With Colon Cancer |
| withdrawn |
| Phase 2 |
| 0 |
| Burzynski Research InstituteOTHER |
| 1 |
| Jul 10, 2013 |
| clinicaltrials |
| NCT01293942 | IXO+A in mCRC With Liver-only Metastases | withdrawn | Phase 2 | 0 | Ottawa Hospital Research InstituteOTHER | 1 | Jun 5, 2013 | clinicaltrials |
| NCT01540435 | Perioperative Treatment of Resectable Liver Metastases(PERIMAX) | withdrawn | Phase 2 | 0 | University of RegensburgOTHER | 0 | May 29, 2013 | clinicaltrials |
| NCT00118105 | S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer | withdrawn | Phase 2 | 0 | SWOG Cancer Research NetworkNETWORK | 1 | Jan 3, 2013 | clinicaltrials |
| NCT00766220 | Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to Liver | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jan 3, 2013 | clinicaltrials |
| NCT00070434 | S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the Rectum | withdrawn | Phase 2 | 0 | SWOG Cancer Research NetworkNETWORK | 0 | Jun 7, 2012 | clinicaltrials |
| NCT00503932 | Proton Therapy With Capecitabine for Rectal Cancer | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Mar 22, 2012 | clinicaltrials |
| NCT00137683 | Colorectal Cancer Control in Appalachian Churches | withdrawn | Phase 2 / Phase 3 | 0 | Centers for Disease Control and PreventionFED | 1 | Mar 14, 2012 | clinicaltrials |
| NCT01175291 | FOLFOX/Bevacizumab +/- MK-0646 in Metastatic Colorectal Cancer | withdrawn | Phase 2 | 0 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 0 | Dec 5, 2011 | clinicaltrials |
| NCT00725400 | Comparative Study of Cetuximab and Radiation Vs Surgery Before or After Radiation in Patients With Colorectal Carcinoma | withdrawn | Phase 2 | 450 | American Scitech InternationalOTHER | 1 | Jul 20, 2011 | clinicaltrials |
| NCT00233623 | Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal Cancer | withdrawn | Phase 2 | 190 | AstraZenecaINDUSTRY | 1 | Jan 27, 2011 | clinicaltrials |
| NCT00988897 | Colorectal Cancer RECHALLENGE | withdrawn | Phase 2 | 0 | SanofiINDUSTRY | 1 | Dec 23, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Mar 7, 2014source: clinicaltrials